Talk:COVID-19 drug repurposing research: Difference between revisions - Wikipedia

Line 156:

Sounds like you are giving me green light.. If you don't respond within 3 hours, I will start writing on this <!-- Template:Unsigned IP --><small class="autosigned">—&nbsp;Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/210.195.8.58|210.195.8.58]] ([[User talk:210.195.8.58#top|talk]]) 00:09, 6 April 2020 (UTC)</small> <!--Autosigned by SineBot-->

== camostat mesylate ==

There is this article on protease inhibitor

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann M1, Kleine-Weber H2, Schroeder S3, Krüger N4, Herrler T5, Erichsen S6, Schiergens TS7, Herrler G8, Wu NH8, Nitsche A9, Müller MA10, Drosten C3, Pöhlmann S11.

https://www.cell.com/cell/fulltext/S0092-8674(20)30229-4

But Matt Hall wrote this on his tweet

"OK so let's talk about camostat, because I'm starting to worry about it as a #COVID19 repurposing candidate. It emerged based on this Cell paper, but a LOT of assumptions are buried in the science."

https://twitter.com/cispt2/status/1246856029012361218

So how?